Reporting Segment Product Line Amount (USD)arrow_drop_down Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Cancer Therapies
Branded Pharmaceuticals (outsourced)
These companies research, develop, and outsource the manufacturing of patented drugs.
30.92M 82.62%
Cancer Therapies
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
6.51M 17.38%
keyboard_arrow_right keyboard_arrow_down
Cancer Therapies
Branded Pharmaceuticals (outsourced)
30.92M 82.62%
keyboard_arrow_right
These companies research, develop, and outsource the manufacturing of patented drugs.
keyboard_arrow_right keyboard_arrow_down
Cancer Therapies
Pre-Revenue Pharmaceuticals
6.51M 17.38%
keyboard_arrow_right
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.